SOHO Italy 2022 | The importance of molecular testing in multiple myeloma and how this may impact future treatment
Claudio Cerchione
• 24 Oct 2022
Claudio Cerchione, MD, PhD, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy, comments on the importance of gene expression profiling and investigating biomarkers of response in multiple myeloma. Dr Cerchione also discusses some ongoing research at his institution, and how this research may improve diagnosis and treatment approaches for patients with myeloma. This interview took place at The 4th Society of Hematologic Oncology (SOHO) Italy Annual Conference, held in Rome, Italy.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
